CARBIOS produces first PET-bottles from 100% recycled plastic waste using Company’s breakthrough technology
CARBIOS (Paris:ALCRB) (Euronext Growth Paris: ALCRB), a company pioneering new, bioindustrial solutions to reinvent the lifecycle of plastic and textile polymers, today announced it has successfully produced the first PET-bottles made with 100% Purified Terephthalic Acid (rPTA), through the enzymatic biorecycling of plastic waste. This major milestone is a world-first and confirms the potential of the company’s technology to engage the whole industry in a responsible transition towards a circular economy.
Alain Marty, Chief Scientific Officer at CARBIOS, comments, “We have successfully developed the first biological process with which all kinds of PET plastic waste can be broken down into its original components and reused to produce virgin plastic products for applications such as PET-bottles. This new step shows the strong potential of CARBIOS’ enzymatic technology and provides a breakthrough solution to help solve society’s growing waste problem.”
Previously, CARBIOS demonstrated that its proprietary biorecycling technology, based on the use of bioengineered enzymes, had the ability to turn PET plastic waste back into its original components at a rate of 97% in only 16 hours. It had also demonstrated that virgin PET can be made with 100% rPTA via its proprietary biorecycling process, which uses all kinds of post-consumer PET plastic bottles (clear, colored, opaque, complex). By demonstrating today that 100% rPTA can be used to produce
PET-bottles that match brand and customer requirements, this technology proves to be a potential game-changer in the transition towards a circular economy that will benefit the environment and future generations.
PET is the most common polyester on the market. It is used to produce plastic packaging, textile fibers, and nearly 500 billion units of plastic bottles each year1. It is a market expected to grow 4.8% annually, from 2017 to 20252. By decoupling the production of new plastic bottles from petrochemical feedstock3 and making waste collection economically more viable, CARBIOS’ technology offers a sustainable and efficient solution to change the way we produce some of the most commonly used plastic products and meet the needs of brand-owners and consumers.
1 Source: Citi GPS - Global Perspectives & Solutions –
Rethinking Single-Use Plastics (August 2018)
2 Source: https://www.recycling-magazine.com/2019/01/24/market-study-sees-lots-of-potential-for-recycled-plastic/
3 See interesting reference: How much oil is used to make plastic? https://www.eia.gov/tools/faqs/faq.php?id=34&t=6
Jean-Claude Lumaret, CEO of CARBIOS, adds, “The plastics industry faces fundamental challenges related to sustainability. Our technology, based on a circular model, reuses resources rather than consuming them. This new milestone takes us one step closer to bringing our technology to the market. With the construction of our demonstration plant to start later this year, we’re aiming to engage the whole plastics industry in a transition towards a circular economy and take a leadership role as a global license provider for the biorecycling of PET plastics and fibers.”
Follow the link to discover more in video: Here
CARBIOS is a green chemistry company whose innovations provide solutions to the environmental and sustainable development issues manufacturers currently face. Since its founding in 2011, the company has developed two industrial-scale biological processes for the biological breakdown and recycling of polymers. These unique innovations help optimise the performance and life cycle of plastics and textiles by capitalizing on the properties of specially selected enzymes. CARBIOS’s economic growth model is based on the industrial roll-out and sale of its products, enzymes, technologies and biological processes through direct licence agreements or joint ventures, to major players in the fields to whom they would most benefit. To that end, CARBIOS founded the joint venture CARBIOLICE in 2016, in partnership with Limagrain Céréales Ingrédients and the SPI fund, run by Bpifrance. This company, in which CARBIOS holds a controlling share, will market the first technology licensed by CARBIOS by producing enzyme pellets used in the production of biodegradable and bio-sourced plastics. Since its founding, CARBIOS has been backed by Truffle Capital, a European investment capital player. CARBIOS qualifies as an “Innovative Company” according to Bpifrance, which makes the company’s shares eligible for inclusion in innovation-focused mutual funds (FCPIs). For more information, please visit: www.carbios.fr
CARBIOS is also eligible for inclusion in SME share savings accounts (PEA-PMEs).
This press release does not constitute and cannot be regarded as constituting an offer to the public, an offer to sell or a subscription offer or as a solicitation to solicit a buy or sell order in any country.
Translation for information purposes only. In case of discrepancy between the French and the English version of this press release, the French version shall prevail.
+33 (0)4 73 86 51 76
Media Relations (Europe)
+33 (0)1 44 54 36 66
Media Relations (U.S.)
Kate L. Barrette
+1 212 223 0561
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Quinbrook Infrastructure Partners Launches with Mercatus26.3.2019 16:00:00 EET | Tiedote
Mercatus, a leading alternative asset and investment management platform, today announced the initial launch of Quinbrook Infrastructure Partners with the Mercatus Investment Lifecycle Management (ILM) Platform. Quinbrook invests in a wide range of low carbon and renewable energy infrastructure assets spanning onshore wind, utility scale and distributed solar PV, battery storage, peaking capacity and ‘smart grids’. Quinbrook recently announced final close on its latest strategy securing over USD 1.6 billion from institutional investors to support ‘value add’ investments in the US, UK and Australian markets. The Mercatus Investment Lifecycle Management (ILM) Platform systematizes and centralizes asset, fund, and portfolio data to give investors accurate analytics and real-time performance, risk, and ESG insights. “Mercatus offered us the fastest time-to-value on our biggest need: streamlining how we work with our rapidly expanding stable of portfolio companies and preparing for the digi
AerSale to Build Next Aero Air / Erickson Aero Tanker for Wildfire Suppression26.3.2019 16:00:00 EET | Tiedote
AerSale ®, a global supplier of mid-life aircraft, engines, used serviceable material, and maintenance, repair, and overhaul (MRO) services, announced today it has signed a contract with Aero Air / Erickson Aero Tanker to build another firefighting air tanker for the company’s fleet at AerSale’s MRO facility in Goodyear, Arizona. Conversion of the 6th MD-87 aircraft, formally begins on April 1 and will mark the sixth such aircraft modification AerSale has completed at Goodyear. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190326005165/en/ AerSale to Build Next Aero Air / Erickson Aero Tanker for Wildfire Suppression (Photo: Business Wire) “The Erickson Aero Tanker is a very versatile fire bomber and we are proud to continue our work to expand their fleet and add more aerial firefighting power to the skies,” said Charlie McDonald, Senior Vice President MRO Services at AerSale. “This modified aircraft will rank among the bes
Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Biktarvy® (Bictegravir, Emtricitabine and Tenofovir Alafenamide) for Treatment of HIV-1 Infection26.3.2019 15:30:00 EET | Tiedote
Gilead Sciences, Inc. (NASDAQ:GILD) announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Biktarvy® (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg, BIC/FTC/TAF), a once-daily single tablet regimen (STR) for the treatment of HIV-1 infection. Biktarvy combines the novel, unboosted integrase strand transfer inhibitor (INSTI) bictegravir, with the demonstrated safety and efficacy profile of the Descovy® (emtricitabine 200 mg/tenofovir alafenamide 25 mg; FTC/TAF) dual nucleoside reverse transcriptase inhibitor (NRTI) backbone, and is the smallest INSTI-based triple-therapy STR available. Biktarvy is the first HIV product that Gilead will launch and commercialize in Japan directly through its local subsidiary, Gilead Sciences K.K. In the United States, Biktarvy has a Boxed Warning in its product label regarding the risk of post-treatment acute exacerbation of hepatitis B. See below for U.S. Important Safety Information as well as the Biktar
Clearpath Brings Velodyne Lidar Technology to Robotics Community as Value-Added Partner26.3.2019 15:00:00 EET | Tiedote
Velodyne Lidar, Inc. today announced Clearpath Robotics has become a value-add partner to offer its groundbreaking lidar sensors for the Clearpath research robot platform. Clearpath Robotics, headquartered in Canada, offers Velodyne sensors to academic and corporate research organizations on its mobile robots for survey and inspection, oil and gas, agriculture, materials handling and other applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190326005148/en/ Clearpath’s robotic solutions utilize Velodyne’s state-of-the-art lidar technology, which boasts industry-leading resolution, range, and field of view. (Photo: Business Wire) Clearpath’s robotic solutions utilize Velodyne’s state-of-the-art lidar technology, which boasts industry-leading resolution, range, and field of view. Velodyne sensors create a 360° real-time map of the environment, allowing the robot to detect and avoid obstacles for safe autonomous naviga
Fifth Annual Fortune 500 Employment Brand Report Published by WilsonHCG26.3.2019 15:00:00 EET | Tiedote
WilsonHCG, a multi-award-winning global talent solutions provider, released its fifth annual Fortune 500 Employment Brand Report. The report analyzes and ranks the employment brand of each of the Fortune 500 companies based on more than 17,000 data points around six key employment branding and promotion categories. It also identifies trends and changes to employee attraction and engagement throughout the hiring process. “Globally, this is the most competitive hiring environment in history,” said John Wilson, CEO of WilsonHCG. “One key finding from the report, many of the high ranked companies are providing candidates with a hyper-personalized experience. A positive and personalized candidate experience is more important than ever before.” Each company within the Fortune 500 was evaluated on the scope of six key employment brand categories grouped into four areas of the hiring process: Awareness & Attraction, Recruitment, Candidate Experience, and Employee Experience. “Executive leaders
ABB Wins Contract to Power the First Chinese-Built Cruise Vessel26.3.2019 14:29:00 EET | Tiedote
ABB has been awarded a contract to supply an integrated package, including two Azipod® steerable propulsion systems, for the construction of China’s first ever home-grown cruise ship. ABB’s deep domain knowledge in cruise technology coupled with its local expertise makes it the perfect partner to support this significant milestone in the evolution of China’s shipbuilding industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190326005501/en/ The Azipod® steerable propulsion systems, also used for the construction of China’s first ever home-grown cruise ship, due for delivery in 2023. (Photo: Business Wire) The 323-meter vessel, due for delivery in 2023, can accommodate 5,000 passengers and is designed to suit the tastes of Chinese cruise travelers whose numbers are expected to rise to 8-10 million annually by 2025, according to industry body Cruise Lines International Association (CLIA). “With this project, China is making
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme